We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Genome Analysis Shows Meiosis Gene Mutation Causes Primary Ovarian Insufficiency

By LabMedica International staff writers
Posted on 28 Dec 2014
A mutation in a gene linked to the process of meiosis was found in two sisters diagnosed with primary ovarian insufficiency (POI), a syndrome that prevented them from reaching sexual maturity.

Mammals and many other organisms achieve reduction and recombination through a process called meiosis, which is recognizable by the presence of a distinctive structure—the synaptonemal complex (SCS), —that links the chromosomes together and is essential for meiosis to complete. More...
The protein encoded by the SYCE1 gene (synaptonemal complex central element 1) may have a role in the synaptonemal complex assembly, stabilization, and recombination. Genes involved in essential steps in chromosome synapsis and recombinations during meiosis, such as SYCE1, have been shown to cause POI in animal models but not in humans.

Investigators at Tel Aviv University (Israel) worked with two daughters of consanguineous parents (first cousins) from a 13-member Israeli-Arab family who had been diagnosed with POI. Genotyping was performed in the patients, their parents, four unaffected siblings, and a group of 90 ethnically matched control individuals.

DNA from the affected sisters was subjected to whole-exome sequencing. The genotypes of interest were confirmed, and genotypes of the additional family members and the control subjects were determined by Sanger sequencing.

Results revealed a nonsense homozygous mutation in the SYCE1 gene in both affected sisters. The parents and three brothers were heterozygous for the mutation, and an unaffected sister did not carry the mutation. The mutation was not identified in the DNA samples from the 90 control subjects.

"One of my main topics of interest is puberty," said first author Dr. Liat de Vries, professor of medicine at Tel Aviv University. "The clinical presentation of the 2 sisters, out of 11 children of first-degree cousins, was interesting. In each of the girls, POI was expressed differently. One had reached puberty and was almost fully developed but did not have menses. The second, 16 years old, showed no signs of development whatsoever. By identifying the genetic mutation, we saved the family a lot of heartache by presenting evidence that any chance of inducing fertility in these two girls is slight. As bad as the news is, at least they will not spend years on fertility treatments and will instead invest efforts in acquiring an egg donation, for example. Knowledge is half the battle—and now the entire family knows it should undergo genetic testing for this mutation."

The paper was published in the July 25, 2014, online edition of the Journal of Clinical Endocrinology and Metabolism.

Related Links:
Tel Aviv University



Gold Member
Veterinary Hematology Analyzer
Exigo H400
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Silver Member
Quality Control Material
NATtrol Chlamydia trachomatis Positive Control
New
Hand-Held Immunofluorescence Analyzer
WS-Si1500
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.